Inventor · disambiguated record
Valeria R. Fantin
Also filed as: FANTIN VALERIA · FANTIN VALERIA R · FANTIN VALERIA ROSA
18 granted patents·18 pending applications·71 citations·filing 2003–2025
93Inventor score
Files withORIC PHARMACEUTICALS INC25AGIOS PHARMACEUTICALS INC2SERVIER PHARMACEUTICALS LLC2DANG LENNY1DANG LEONARD LUAN C1
Top patents by PatentIndex Score
36 records- 0196US11028120B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Jun 8, 2021·10 cites·30 claims
- 0295US12018043B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·6 cites·33 claims
- 0395US11130778B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2021·Granted Sep 28, 2021·8 cites·30 claims
- 0494US11530236B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·4 cites·25 claims
- 0594US10610125B2Methods and compositions for cell-proliferation-related disordersAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Apr 7, 2020·9 cites·12 claims
- 0693US11325938B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·9 cites·20 claims
- 0791US11129841B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2018·Granted Sep 28, 2021·7 cites·20 claims
- 0890US9434979B2Methods and compositions for cell-proliferation-related disordersSU SHIN-SAN MICHAEL·Filed 2012·Granted Sep 6, 2016·7 cites·7 claims
- 0990US2025378926A1Methods and compositions for cell-proliferation-related disordersSERVIER PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1088US11377469B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2018·Granted Jul 5, 2022·5 cites·19 claims
- 1187US12454544B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2024·Granted Oct 28, 2025·0 cites·9 claims
- 1286US11576922B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2021·Granted Feb 14, 2023·1 cites·41 claims
- 1385US11807658B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Nov 7, 2023·1 cites·19 claims
- 1483US2024071588A1Methods and compositions for cell-proliferation-related disordersSERVIER PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1583US2025368677A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1679US11124537B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 21, 2021·1 cites·23 claims
- 1776US10723759B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·28 claims
- 1876US2023096870A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1976US2024124512A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2071US7919261B2Methods for predicting treatment response based on the expression profiles of protein and transcription biomarkersMERCK SHARP & DOHME·Filed 2006·Granted Apr 5, 2011·3 cites·1 claims
- 2171US2020281501A1Methods and compositions for cell-proliferation-related disordersAGIOS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2270US10836789B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·0 cites·30 claims
- 2369US2021017219A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2467US2022259253A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2564US2021379084A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2663US2014187435A1Methods and compositions for cell-proliferation-related disordersDANG LEONARD LUAN C·Filed 2013·Application pending·0 cites
- 2761US2021395295A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2859US11110103B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 7, 2021·0 cites·12 claims
- 2955US2012121515A1Methods and compositions for cell-proliferation-related disordersDANG LENNY·Filed 2010·Application pending·0 cites
- 3051US2004097408A1Compounds regulating cell proliferation and differentiationFiled 2003·Application pending·0 cites
- 3149US2021380680A1Anti-claudin antibodies and uses thereofZLLP HOLDING LTD·Filed 2019·Application pending·0 cites
- 3247US2021147472A1Solid forms and formulations comprising a glucocorticoid receptor antagonist and uses thereofORIC PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3346US2021122730A1Glucocorticoid receptor modulatorsORIC PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3444US2022079924A1Glucocorticoid receptor modulatorsORIC PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3542US11208432B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Dec 28, 2021·0 cites·35 claims
- 3642US2013197106A1Methods of identifying a candidate compoundFANTIN VALERIA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Valeria R. Fantin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →